Christopher Thatcher serves as the President and CEO of Noxilizer, Inc., leading advancements in sterilization technology for the pharma, biotech, and medical device industries. With extensive experience as a Senior Life Sciences Executive, Christopher has held various strategic roles, including CEO of Neuronetics, where significant revenue growth and successful IPO were achieved. Christopher's career spans impactful positions at companies such as IGT, LLC, Allergan, Bausch & Lomb, and Integra LifeSciences, focusing on commercialization of medical devices, operational efficiency, and market expansion. An advisor at Sinaptica Therapeutics and a board member at Micro Interventional Devices, Christopher continues to influence innovations in the healthcare sector. Christopher holds a BA from Lafayette College and completed executive education at Columbia Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices